A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)
一项针对复发性或难治性实体瘤儿童、青少年或年轻成人的pepinemab 1/2期研究：儿童肿瘤协作组联盟报告（ADVL1614）
期刊:Pediatric Blood & Cancer
影响因子:2.3
doi:10.1002/pbc.30938
Greengard, Emily; Williams, Robin; Moriarity, Branden; Liu, Xiaowei; Minard, Charles G; Reid, Joel M; Fisher, Terrence; Evans, Elizabeth; Pastore, Desa Rae; Zauderer, Maurice; Voss, Stephan; Fox, Elizabeth; Weigel, Brenda J
